Assoc Prof. Cristian Serafinceanu: Institutul de Diabet, Nutri Ţie Şi Boli Metabolice "N. Paulescu" Bucharest
Assoc Prof. Cristian Serafinceanu: Institutul de Diabet, Nutri Ţie Şi Boli Metabolice "N. Paulescu" Bucharest
Assoc Prof. Cristian Serafinceanu: Institutul de Diabet, Nutri Ţie Şi Boli Metabolice "N. Paulescu" Bucharest
Institutul
nutritional screening
nutritional antecedents
nutritional behavior
clinical examination
biologic parameters
Periodic evaluation:
1. results monitoring - redefining goals
1. solving current problems
Significant antecedents:
1.
Physiologic
Pathologic
Therapeutic
1.
2.
Age
BMI
Malnutrition
>= 18 years
<16
16 16,9
17 18,5
>= 18,6
Severe
Moderate
Mild
Normal
14 17 years
<16,5
Present
11 13 years
<15
Present
Living environment
-poor income
-lives alone
-housebound
-is unable (or prefers not) to spend money on food
-bathing
-dressing
-toileting (grooming)
-eating (preparing food)
-walking (traveling)
-shopping (for food)
Target
population
Mid-arm
circumference
(MAC)
Triceps
skinfold
(TS)
Mid-arm
muscle area
(MAMA)
Females 3040y
28.6
24.2
32.4
Females 6070y
31.7
14.5
35.4
Males 30-40y
31.9
13
55.8
Males 60-70y
32.8
14.2
51
Mechanism
Inadequate intake
Inadequate
absorption
History of
Suspected
deficiency
Alcohol abuse
Protein, vitamins B
Avoidance of fruits,
vegetables
Vitamin C, folates,
vitamins B
Avoidance of meat ,
Protein, vitamin B12
eggs
Habitual
constipation
Dietary fibre
Poverty, isolation
Energy, protein
Drugs (antacids,
laxatives,
anticonvulsivants)
Various nutrients
Mechanism
History of
Malabsorption (diarrhea,
weight loss, steatorrhea)
Inadequate
absorption
Suspected
deficiency
Liposoluble
vitamins
(A,D,E,K),
energy, protein
Parasites
Pernicious anemia
Gastro-intestinal surgery
Decreased
utilization
Drugs
(anticonvulsivants,
antimetabolites,
isoniazide)
Inborn errors of
metabolism
Various
Mechanism
Increased losses
History of
Suspected
deficiency
Alcohol abuse
Magnesium, zinc
Blood loss
Iron
Centesis (ascitic,
pleural)
Uncontrolled
diabetes mellitus
Protein
Energy, protein
Diarrhea
Protein,
electrolytes
Nephrotic
syndrome
Protein
Dialysis
Protein, vitamins
(water soluble)
Mechanism
Increased
requirements
History of
Suspected
deficiency
Fever,
hyperthyroidism
Physiologic
demands
(adolescence,
pregnancy,
lactation)
Surgery, burns,
trauma
Energy, protein,
vitamin C
Infection, hypoxia
Energy
Smoking
Vitamin C, folates
Energy
Energy, various
nutrients
Organ
/syste
m
Nutritional deficiency
Non-nutritional
association
environmental
niacin or tryptophan
chemical burns,
Addisons disease
pallor
hemorrhage,
pigmentation
disorders
Petechiae,
ecchymoses
Vit K, C
nails
spoon-shaped
iron
pulmonary or heart
chronic disease
hair
hypothyroidism,
chemotherapy,
psoriasis
Abnormal finding
dry, scaly
Skin
hyperpigmentation of
sunlight exposed
areas
Organ/system
Abnormal finding
Nutritional
deficiency
Non-nutritional
association
eyes
Vit A
Gauchers disease
lips
bilateral (angular
stomatitis) or
vertical cracks
(cheilosis)
dentures problems,
herpes, syphilis,
AIDS
tongue
magenta, loss of
papillae, swollen
Vit B2
Crohndisease,
bacterial or fungal
infections
Vit. C
Drugs (dilantin),
lymphoma,
thrombocytopenia,
aging, poor dental
hygiene
Protein deficiency
Tumors,
hyperparathyroidis
m
gums
spongy, bleeding,
receding
parotid glands
Bilateral
enlargement
visceral
somatic
Salb
Sprealb
Stransf
Ret. bind. prot.
IGF-1
Other methods
SGA
Anthropometry
BIA
Nitrogen balance
Densitometry
Creat. Kinetics
Isotope studies
DEXA
NMR
others
Energy balance
expenditure
balance
Normal
function
Nutritional
significance
Albumin
35-45
18-20
Coloid-osmotic
pressure
late malnutrition
marker
Transferrin
2.6-4.3
8-9
plasma iron
carrier
malnutrition (more
early) marker; negative
inflammation marker
Prealbumin
(transthyreti
n)
0.2-0.4
2-3
Thyroid
hormones
transporter
Malnutrition (early
marker); acute
hypercatabolic states
Rhetynol
binding
protein
(RBP)
0.37
0.5 (12h)
Pro-vitamin A
transporter
Proteic intake
markerhypercatabolic
states
Insulin-like
growth
factor 1 (IGF
1)
0.55-1.4
UI/ml
2-6 h
Anabolic growth
factor
Immediate proteic
intake marker
1. Weight Change
Maximum body weight _______________
Weight 6 months ago _______________
Current weight
_______________
_______no change
________decrease
_________Change
__________ Vomiting
____________ Diarrhea
___________ Anorexia
4. Functional Capacity
___________ NO dysfunction
___________ Dysfunction
PHYSICAL EXAMINATION
(For each trait specify: 0 = normal; 1+ = mild; 2+ = moderate; 3+ = severe)
__________ Loss of subcutaneous fat (shoulders, triceps, chest, hands)
__________ Muscle wasting (quadriceps, deltoids)
__________ Ankle edema
__________ Ascites
Parameter
/score
Weight
changes/6
mo
no
5%
5-10%
10-15%
15%
Dietary
intake
changes/ 6
mo
no
Suboptimal
solid food
Moderate
global
decrease
Liquid/hypocalo
ric diet
starvation
Digestive
symptoms
no
nausea
Vomiting/othe
r moderate
Frequent
diarrhea/vomiti
ng
Anorexia
Functional
status
Good/norm
al for age
Walking
difficulty
Usual efforts
difficulty
(housekeeping
)
Minimal efforts
difficulty
(toileting)
Bedriding
Comorbidities
No
mild
moderate
1 severe
Multiple,
severe
Dialysis
duration**
Less than 12
mo, RRF
Less than 12
mo, no RRF
More than 48
mo
Malnutrition:
-absent: 0 4
-mild:
58
-moderate: 9 14
-severe: 15 -24
1.
Normal: 90-110%
Mild deficit: 80-89%
Moderate deficit: 70-79%
Severe deficit: <70% (or with oedemas)
Bones, joints
Iron status.
Calcium and phosphorus status.
Vitamins status.
a.
23 mg/Kgc/day in men
18 mg/Kgc/day in women
Males
Females
Height (cm)
Urinary
creatinine /24h
(mg)
Height (cm)
Urinary
creatinine /24h
(mg)
160
1325
150
851
165
1386
155
900
170
1467
160
950
180
1642
165
1001
185
1739
170
1076
190
1831
175
1141
1)
2)
3)
4)
Nutrient
Recommended Intake
Saturated
fat
Polyunsaturated fat
Monounsaturated fat
Total fat
Carbohydrate
Fiber
Protein
Cholesterol
Total calories (energy)
Stanol esters
Soy protein
Soluble fiber
Fish
Less Atherogenic
Unsaturated Fatty Acids
Hydrogenated
Vegetable Oils
Trans
Fatty Acids
Cocoa Butter
Coconut Oil
Palm Oil
Polyunsaturated
Fatty Acids
Omega-6
Fatty Acids
Omega-3
Fatty Acids
Corn, Safflower,
Sunflower,
Soybean
Fish, Flaxseed,
Soybean,
Marine Vegetation
Shortening
Margarine
Monounsaturated
Fatty Acids
Olive Oil,
Canola Oil,
Nuts, Avocado
Lifestyle issues:
Source: The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure JNC VII. JAMA. 2003;289:2560-2572.
Each group spent 30 days on each 1150, 2300, and 3450 mg Na/day
Effects of reduced sodium seen in both patients with normal and high
blood pressure regardless of race or gender.
Modification
Recommendations
Approximate Systolic
Blood Pressure
Reduction
Weight Reduction
8-14 mm Hg
2-8 mm Hg
4-9 mm Hg
2-4 mm Hg
DASH PYRAMID
Year
8.4
8.2
8.0
HgbA1C
7.8
7.6
7.4
7.2
No Education
7.0
1 RD visit
6.8
3 RD visits
6.6
Initial
6 Week
3 Month
6 Month